Shaida Khan

MedicineEnvironmental ScienceNeuroscience

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 3 papers. Top paper: “Switching to subcutaneous zilucoplan from intravenous complement component 5 inhibitors in generalised myasthenia gravis: a phase IIIb, open-label study”.

Switching to subcutaneous zilucoplan from intravenous complement component 5 inhibitors in generalised myasthenia gravis: a phase IIIb, open-label study

Therapeutic Advances in Neurological Disorders(2025)10.1177/17562864251347283

N/A

0.344DataRank · unranked

6 citations

Urvi Desai, Raghav Govindarajan, Min Kyun Kang, Shaida Khan, Bhupendra Khatri +11 more

Development of a standard of care for patients with valosin-containing protein associated multisystem proteinopathy

Orphanet Journal of Rare Diseases(2022)10.1186/s13023-022-02172-5

N/A

0DataRank · unranked

36 citations

Allison Peck, Lindsay N. Alfano, Kenneth I. Berger, M. James, Nupur Ghoshal +50 more

Subcutaneous batoclimab in generalized myasthenia gravis: Results from a Phase 2a trial with an open‐label extension

Annals of Clinical and Translational Neurology(2023)10.1002/acn3.51946

N/A

0DataRank · unranked

20 citations

Ari Breiner, Vera Bril, Jeffrey A. Allen, Shaida Khan, Todd Levine +8 more